Patients with AMD may have better outcomes with ForeseeHome monitoring
Click Here to Manage Email Alerts
NEW YORK — Patients with age-related macular degeneration who underwent ForeseeHome monitoring experienced good long-term visual acuity outcomes, according to a study.
At the American Society of Retina Specialists annual meeting, Michael J. Elman, MD, presented the results of a retrospective review that aimed to determine whether remote monitoring with the ForeseeHome (Notal Vision) and the Notal Vision Monitoring Center along with regular physician care resulted in better long-term visual acuity outcomes and early detection of neovascular AMD conversion.
Elman and colleagues reviewed 3,334 eyes of 2,123 patients with intermediate AMD from August 2010 to July 2020. Visual acuity at baseline, visual acuity at conversion to neovascular AMD and visual acuity at the most recent visit were evaluated, as well as frequency of home testing.
The patients were monitored with a total of 1,706,433 tests in 10,474 eye-monitoring years. Median visual acuity was 20/30 at the start of the program, 20/39 at conversion to neovascular AMD and 20/32 at the most recent visit. Additionally, 84% of patients maintained vision of 20/40 or better at conversion, with 82% maintaining 20/40 or better at the most recent visit.
Elman said that the monitoring center resulted in “excellent” patient compliance and that the ForeseeHome prevented patients from being undertreated.
“This is a new model that allows us to catch AMD sooner and provide better outcomes for patients,” he said. “ForeseeHome-based monitoring has allowed nearly twice as many patients to keep functional measures. All the elements — the home device, the monitoring center and the physician’s office — play a critical role. This is a proven model that can be extended for other remote care monitoring applications.”
Collapse
Elman M. Analysis of the long-term visual outcomes of ForeseeHome remote telemonitoring. Presented at: American Society of Retina Specialists annual meeting; July 13-16, 2022; New York.
Read more about
Click Here to Manage Email Alerts